Lyclear

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lyclear

Lyclear: What Kind of Medicine Is It?

Property Description
Active ingredient Permethrin
Form Dermal Cream, Lotion, Solution
Pharmacological class Ectoparasiticide
Common use Elimination of parasitic infestations
Origin Synthetic pyrethroid

Lyclear: Definition, Classification, and Form

Lyclear is a potent topical medicinal preparation that is formally classified as an ectoparasiticide, a pharmacological category dedicated to the elimination of parasites that infest the external surfaces of the body, such as the skin and hair. As an example of a monotherapy, it contains a single active ingredient designed exclusively for external use. Permethrin preparations are recognized for their efficacy in treating ectoparasitic infections, which underscores the drug's established role in healthcare systems. Lyclear is typically supplied in dermal cream and lotion formulations, which are practical vehicles optimized for uniform topical application, a form often preferred for ease of self-administration.

Composition: The Role of Permethrin

The core ingredient providing Lyclear its efficacy is Permethrin. Permethrin is defined as a synthetic pyrethroid, a chemical family that mimics the natural insecticidal compounds found in certain chrysanthemum flowers, ensuring its consistent stability and potency. The composition centers on incorporating this substance into a suitable cream base or aqueous solution vehicle containing non-active emulsifiers necessary for proper distribution. Permethrin is a clinically recognized first-line topical treatment against common ectoparasitic conditions. Pharmacological studies confirm its ability to achieve both insecticidal and ovicidal action, which is a critical feature distinguishing it from agents that only kill adult pests.

General Therapeutic Purpose

The fundamental utility of Lyclear is derived from the neurotoxic mechanism of Permethrin. By disrupting sodium transport across their nerve cell membranes, the substance causes rapid overstimulation and subsequent paralysis. This targeted action is supported by decades of clinical application, confirming its ability to swiftly eliminate the parasitic burden. The general therapeutic purpose is to achieve the definitive clearance of the infestation, thereby resolving the intense localized discomfort and halting the spread of the parasites.

Regulatory References

  1. Model List of Essential Medicines

What side effects are possible with Lyclear?

Possible Side Effects and Safety Information

Lyclear, which contains the active substance Permethrin, has a safety profile that is primarily characterized by effects related to its topical application as an ectoparasiticide. All documented adverse reactions are based on official classifications provided by regulatory bodies.

Adverse Reaction Categories

The majority of side effects are categorized under Skin and subcutaneous tissue disorders. These effects are generally observed as common in regulatory documents and may include localized symptoms such as pruritus (itching), erythema (redness), and burning or stinging sensations on the skin. Reactions affecting the Nervous system disorders class, such as headache, are listed as uncommon.

Time-Related Patterns: Official prescribing information notes that temporary localized skin discomfort, such as burning, may appear at the beginning of treatment and is typically described as mild and transient. Itching may occasionally persist for several weeks after the elimination of parasites, which is often considered a non-allergic post-treatment symptom.

Serious Safety Constraints

The most significant safety restriction documented in regulatory labels is the contraindication for individuals with a known hypersensitivity to the active ingredient, Permethrin, other synthetic pyrethroids, or any components of the formulation. Severe hypersensitivity reactions are officially documented as rare serious adverse reactions.

Population-Specific Safety: The medication’s safety profile is established for use in paediatric patients two months of age and older for the approved indications. Regulatory data does not currently support its use in infants younger than two months of age. The formulation is strictly for external use only.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the required emergency response for Lyclear (Permethrin topical) based on the route of exposure. There are no reports of overdosage of the topical cream in the official prescribing information; however, protocols are established for scenarios involving excessive application or accidental ingestion.

Documented Overdose Manifestations

Exposure Scenario Officially Documented Manifestations
Accidental Ingestion Symptoms may include nausea, vomiting, dizziness, and headache. A severe documented outcome is convulsion.
Excessive Topical Use Localized skin reactions such as increased irritation and erythema (redness) are described.

Required Emergency Actions

If the product is accidentally ingested, immediate action is required to manage potential systemic effects. Regulatory guidance mandates that individuals seek immediate medical attention and contact a poison control center. Supportive measures, such as gastric lavage, should be considered if the consultation occurs within two hours of ingestion, and general supportive measures should be employed. Furthermore, if the individual has collapsed or is not breathing due to potential overdose, official drug guidance requires that local emergency services be contacted immediately.

Therapeutic Uses of Lyclear

Lyclear Therapeutic Overview

Lyclear is a topical medication used to manage certain parasitic infestations affecting the skin. The treatment is indicated for the resolution of infestation with scabies, a common skin condition caused by the Sarcoptes scabiei mite. This involves applying the cream to the whole body to eliminate the mites and their eggs.

Additionally, Lyclear is indicated for the treatment of crab lice (Pthirus pubis), also known as pubic lice. Its use is associated with benefits in eliminating the lice and preventing the continuation of the infestation.

Clinical data suggests that the medication is an important option for patients diagnosed with these conditions. Following appropriate application, the formulation is designed to support the eradication of the parasites.


Quick Facts: Main Uses

  • Scabies: Used to assist in the eradication of the Sarcoptes scabiei mite infestation.
  • Crab Lice: Indicated for the management and resolution of infestation with Pthirus pubis (pubic lice).

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Lyclear?

The population eligibility for Lyclear (Permethrin 5% cream) is strictly defined by regulatory documents, focusing on patient age and pre-existing hypersensitivities.


Absolute Contraindication

Use of this medicine is contraindicated in patients with known hypersensitivity to the active ingredient, Permethrin, to any component of the specific formulation, or to other synthetic pyrethroids or pyrethrins.


Age-Based Eligibility

The medicine is established as suitable for use in adults and older adults. For pediatric populations, regulatory labeling defines a minimum threshold:

  • Allowed: Children two months of age and older.
  • Not Recommended: Safety and effectiveness have not been established in infants less than two months of age.

Special Population Restrictions

  • Pregnancy: Permethrin is classified as Pregnancy Category B. Use during pregnancy is conditional and is permitted only if clearly needed, based on official regulatory risk assessment.
  • Lactation: Consideration should be given to discontinuing nursing or withholding the drug during the treatment period, as it is not known if Permethrin is excreted in human milk.
  • Comorbidities: Caution is advised for patients with known allergies to chrysanthemums or other Compositae plants, as these are chemically related to Permethrin.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lyclear (permethrin) is a topical medication, and its official prescribing information indicates a minimal risk for systemic drug interactions due to its very low absorption into the bloodstream (less than 2% of the applied dose). Regulatory documents confirm that no systemic pharmacokinetic interactions are known or have been established, including those involving major metabolic enzymes (e.g., CYP450) or drug transporters.


The most significant documented interaction is pharmacodynamic and relates to its use with other topical treatments.

Documented Interaction

Interacting Substance Category Interaction Summary and Restriction
Topical Corticosteroids Treatment of eczematous-like reactions with topical corticosteroids should be withheld prior to Lyclear application. The restriction is a procedural constraint designed to prevent the risk of exacerbating the underlying mite infestation by reducing the local immune response.

Undocumented Systemic Interactions

Regulatory agencies state that interactions with systemically administered medicines have not been established. There are no known restrictions regarding the co-administration of oral or injectable medicines with Lyclear. Additionally, interactions with food, alcohol, or herbal products are not documented in the official prescribing information.

Mechanism of Action

Targeting Voltage-Sensitive Sodium Channels

The active ingredient, Permethrin, acts by binding directly to the voltage-sensitive sodium channels on the nerve cell membranes of the target parasites. This molecular interaction prevents the channels from inactivating, resulting in a prolonged influx of sodium ions that initiates the mechanistic cascade.

Mechanistic Cascade to Irreversible Paralysis

The sustained, uncontrolled influx of sodium ions leads to persistent membrane depolarization and hyperexcitation of the parasite's nervous system. This overstimulation rapidly progresses to irreversible physical paralysis and subsequent demise of the organism, which constitutes the resulting physiological effect on the parasite.

Dual Action: Insecticidal and Ovicidal Effect

Permethrin's mechanism extends beyond killing adult organisms (insecticidal action) to include ovicidal action, where the compound disrupts the developmental processes within the parasite's eggs. This leads to life-cycle disruption, which is the biological basis for clearance of the organism and its developmental stages.

Mechanism Limitations: Resistance

The drug's effectiveness is constrained by two biological resistance mechanisms: target-site insensitivity (genetic alteration of the sodium channel, reducing Permethrin binding) and metabolic resistance (enhanced enzymatic detoxification of the molecule). These mechanisms prevent the required threshold of neurotoxicity from being reached, which is a documented limitation of the mechanism.

Dosage and Administration Information

How to Use Lyclear: Official Administration Guidelines

The usage of Lyclear (Permethrin 5% cream) follows a precise protocol detailing the administration route, duration, and re-treatment schedule.


Administration Scope

Category Official Use Protocol
Route of Administration Restricted to topical or cutaneous application only.
Dosing Schedule (Adults) A single application dose of up to 30 grams (one 30 g tube) is standard for an average adult, with larger individuals potentially requiring up to 60 grams for full coverage.
Age-Group Rules The medication is approved for use in infants 2 months and older. For infants and older adults, application must explicitly include the face, ears, and scalp, a modification from the standard adult protocol.
Preparation and Timing The cream must be applied to clean, cool, dry skin and should not be used immediately following a hot bath.

Resulting Procedural Structure

The entire course of use is structured around a single application with a mandated contact time. The cream must be thoroughly massaged into the skin, avoiding contact with mucous membranes, and then left on the body for a required duration of 8 to 14 hours. If the hands are washed during this retention period, the cream must be immediately reapplied to the hands and wrists. Following the contact time, the medication is removed by washing with water and soap.

A single application is typically sufficient. However, if evidence of live infestation persists, a second treatment may be carried out not less than 7 days after the first.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lyclear

Evidence for Use in Scabies

Clinical research exploring topical Permethrin for scabies is available, primarily through Randomized Controlled Trials (RCTs). These short-term clinical trials were applied in studies examining how outcomes, such as the complete clearance of the parasite and tracking changes in outcomes related to physical discomfort (itching or pruritus), change over defined time intervals. The populations in these studies included both adults and children, often including young infants, and research was conducted in various clinical and community-based settings.

Studies reported measurements of clinical status in the observed populations during the study period. Research highlights the measurement of parasite clearance rates and patterns of change in the intensity of itching assessed during the study period. Findings describe patterns observed in the studies that included various comparator treatments.

Evidence for Use in Crab Lice (Pubic Lice)

Permethrin was studied for the treatment of crab lice, also known as Pthirus pubis. The evidence base for this condition consists of clinical trials and systematic reviews that have explored the use of this medicine topically. Studies monitored the primary outcome of parasite clearance, which includes confirming the elimination of both the live lice and their eggs (nits). Research primarily involved adult populations.

There are fewer recent, large-scale RCTs focusing exclusively on crab lice compared to the available evidence for scabies. Consequently, comparative evidence is sometimes lacking, and the data are still emerging for certain specific scenarios.

Research Gaps and Areas of Uncertainty

What remains uncertain is the long-term durability of these reported outcomes. Follow-up durations were often limited to 2 to 4 weeks, meaning there is limited information for long-term outcomes, and the duration for which the observed response lasts beyond the first month is not fully established. Furthermore, ongoing research examines the potential for treatment failure due to the development of parasite resistance to Permethrin in various parts of the world. Data for certain groups remain insufficient, particularly for pregnant individuals and patients with certain pre-existing skin conditions.

Key Studies & References

  1. Permethrin Versus Benzyl Benzoate for the Treatment of Scabies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  2. Permethrin (topical route) - MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Lyclear (FAQ)

Q: How is Lyclear cream different from the Lyclear rinse product?

A: Official information describes different formulations of Permethrin that are used for specific purposes. The Permethrin 5% cream is commonly used to treat scabies, while the 1% formulation (lotion or rinse) is typically used for head lice. These different concentrations and forms have distinct usage directions and required application times.

Q: Is Lyclear safe to use during pregnancy or while breastfeeding?

A: Permethrin is classified by regulatory bodies as Pregnancy Category B. Official documents state that use during pregnancy is conditional and is permitted only if clearly needed based on the assessment of a healthcare provider. Regarding breastfeeding, it is unknown whether the substance passes into human milk, although the risk to the infant is considered low due to the substance's very low systemic absorption. Healthcare providers may advise considering discontinuing nursing or withholding the drug during the treatment period.

Q: Is the itching sometimes worse after the Lyclear treatment, and is that normal?

A: Official data indicates that common local effects, such as temporary burning or stinging, may appear at the beginning of treatment. Furthermore, symptoms related to the underlying infestation, like itching, redness, or swelling, may temporarily worsen or persist even after the parasites have been eliminated.

Q: How long can itching or rash continue after using Lyclear, even if the mites are gone?

A: Itching, or pruritus, is a common post-treatment symptom that may occasionally persist for several weeks after the parasites are confirmed to be cleared. Official information indicates that this prolonged itching is often a non-allergic post-treatment symptom and does not necessarily indicate a failure of the medication.

Q: Can Lyclear be used on other parts of the body besides the scalp or main affected areas?

A: For the treatment of scabies, the 5% Permethrin cream is generally applied uniformly to the whole body from the neck down to the soles of the feet. While the head and face may be spared in adults unless infested, the goal is total body coverage to ensure the parasite is eliminated from all affected areas.

Q: What should I do if Lyclear accidentally gets into my eyes?

A: Official patient information advises strictly avoiding contact with the eyes and other mucous membranes. If the product accidentally enters the eyes, the area should be flushed immediately and thoroughly with large amounts of water. If irritation continues after thorough flushing, consulting a healthcare professional is noted in the guidance.

Q: Can Lyclear affect conditions like asthma or eczema?

A: Regulatory documents advise caution for patients with certain allergies, noting that the product may potentially cause breathing difficulties or asthmatic episodes in individuals allergic to pyrethrins or pyrethroids. Furthermore, it is advised that treatment of eczematous-like skin reactions with topical corticosteroids should be temporarily withheld prior to Lyclear application.

Q: Is Lyclear still effective if it's applied for a shorter time than the instructions recommend?

A: Official directions require the cream to be left on the skin for a mandated minimum contact time, often between 8 to 14 hours. Following the correct application protocol is crucial, and failing to adhere to the required time period may affect the treatment's efficacy.

Q: Do studies suggest that head lice or mites can become resistant to Lyclear?

A: Yes, regulatory-cited evidence acknowledges that resistance to Permethrin has been documented in various parts of the world. Studies suggest resistance can develop through changes in the parasite's nervous system or increased ability to detoxify the medicine, which is a known limitation of this drug class.

Q: Is Lyclear available over the counter, or is a prescription needed?

A: The Permethrin 5% cream used to treat scabies is commonly available for purchase without a prescription in many regions. However, product availability and regulatory status can vary by country and specific product strength.

Q: Are there different strengths of Lyclear, and what are they used for?

A: Regulatory data references different strengths, including a 5% cream primarily for the treatment of scabies, and a 1% lotion or rinse which is indicated for the treatment of head lice. The concentrations and application times differ based on the parasitic condition being treated.

Q: What are the known potential risks of Lyclear beyond the common mild side effects?

A: Official documentation lists rare but serious potential risks, including severe hypersensitivity reactions (allergic reactions). The official guidance states that severe allergic reactions require prompt medical assessment.

Q: How long does the active ingredient in Lyclear remain on or in the skin?

A: Permethrin is known to be minimally absorbed into the bloodstream, with less than 2% typically entering the system. The small amount that is absorbed is rapidly metabolized into inactive substances and excreted in the urine, with metabolites being detectable for several days after application.

Q: Does Lyclear kill both the mites/lice and their eggs?

A: Yes, official prescribing information confirms that the active ingredient, Permethrin, is documented to have dual action. It provides both an insecticidal effect (killing the adult organisms) and an ovicidal effect (disrupting the life cycle by killing the eggs).

Q: How is Lyclear treatment related to washing clothes and bedding?

A: Official health guidelines recommend washing clothing, bedding, towels, and other items used by the infested person during the 2–3 days before treatment. These items should be washed in very hot water and dried on a hot cycle to eliminate any surviving parasites.

Q: Can Lyclear treatment be done if a person has a pre-existing skin irritation or open wounds?

A: Official instructions advise against applying the cream to broken skin or open wounds, as the medicine itself may cause marked irritation in these areas. Caution is advised, and official information suggests consulting a healthcare professional for individuals with pre-existing severe skin inflammation.

Q: Is there any known interaction between Lyclear and hormonal birth control (like condoms)?

A: Official regulatory documents confirm that due to its very low absorption into the bloodstream (less than 2%), no systemic pharmacokinetic interactions are known or have been established with systemically administered medicines, which includes hormonal birth control.

Q: Is it necessary to clean the entire house or just clothing after a Lyclear treatment?

A: Health guidelines typically recommend cleaning clothes, bedding, and towels. Additionally, thorough vacuuming of upholstered furniture, rugs, and floors in the home is advised as part of the overall strategy to prevent re-infestation.

Q: Can Lyclear be used to treat other parasites besides the primary targets (scabies or lice)?

A: Permethrin is formally indicated and approved by regulatory bodies for the treatment of Sarcoptes scabiei (scabies) and Pediculosis capitis (head lice). Its efficacy for other parasites is not part of the established primary indications.

Q: Does the application of Lyclear cause a strong smell or noticeable residue on the skin/hair?

A: Official documents often describe the 5% cream as a 'vanishing cream' that, when rubbed gently into the skin, should disappear. If applied according to the instructions, the expectation is that a noticeable residue should not remain.

Q: Can Lyclear worsen the symptoms of a severe scalp or skin inflammation?

A: Official patient information advises that the use of Permethrin may make a pre-existing condition, such as severe inflammation of the scalp, worse. The cream is also noted to cause localized irritation upon contact with broken skin.

Q: What should I do if I accidentally swallow a small amount of Lyclear?

A: The product is for external use only. In the event of accidental ingestion, contacting a Poison Control Center is advised, and healthcare providers may consider specific actions, such as gastric lavage, within the first few hours.

Q: Why are the face and head usually spared during Lyclear cream application in adults?

A: The head and face are typically spared in adults unless the infestation (scabies lesions) is specifically present in those areas. This is a modification of the standard protocol, which generally requires application to the whole body from the neck down.

Q: Are there different application instructions for Lyclear cream when treating crab lice versus scabies?

A: Official guidelines outline slightly different application protocols based on the condition being treated. For scabies, the 5% cream is applied to the whole body and typically left on for 8–14 hours. For crab lice (pubic lice), a different Permethrin strength is often used, and the treatment is usually applied to the infested area and rinsed off after a shorter period.

Q: Why is it important to treat close contacts (family/partners) even if they don't have symptoms yet?

A: Public health guidance recommends that all close contacts, including household and sexual partners, should be treated at the same time as the primary patient, even if they show no symptoms. This approach is intended to prevent re-infestation of the index case and to help halt the spread of the parasites.

Q: What is the recommended approach for treating a child's hands after Lyclear application to prevent accidental ingestion?

A: Official administration instructions for pediatric patients state that special care should be taken to prevent children from licking the cream from their hands, which could lead to accidental ingestion. If necessary, children should wear gloves during the entire mandated treatment period.

How should Lyclear be stored and disposed of?

Storage and Disposal Requirements for Permethrin Cream (Lyclear)

Permethrin cream must be stored according to official regulatory labeling to ensure product integrity.

Storage Conditions

Requirement Official Instruction
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep from freezing and protect from excessive heat, moisture, and direct light.
Container Store in the original container and keep it tightly closed.
Safety Keep out of the sight and reach of children.

Disposal

Unused or expired Lyclear must be disposed of in accordance with local regulatory requirements for waste medicine. It is a mandatory environmental instruction to not empty the product into drains, sewers, or waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lyclear found in:

A-Z Index: